Results 211 to 220 of about 297,240 (266)

Safety evaluation of an extension of use of the food enzyme α-amylase from the genetically modified <i>Bacillus licheniformis</i> strain NZYM-BC. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Solano MLM, Van Loveren H, Vernis L, Bonino I, Cavanna D, Liu Y.   +15 more
europepmc   +1 more source

Safety evaluation of the food enzyme pectinesterase from the non-genetically modified <i>Aspergillus luchuensis</i> strain CBS 148463. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Solano MLM, Van Loveren H, Vernis L, Aguilera J, Andryszkiewicz M, Criado A, Pesce F, Liu Y.   +17 more
europepmc   +1 more source

Safety evaluation of the food enzyme trypsin from the genetically modified <i>Fusarium venenatum</i> strain NZYM-FG. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Baviera JMB, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Solano MLM, Van Loveren H, Vernis L, Peluso S, Andryszkiewicz M, Cavanna D, Fernandez-Fraguas C, Criado A, Roos Y, Liu Y.   +19 more
europepmc   +1 more source

Safety evaluation of an extension of use of the food enzyme subtilisin from the genetically modified <i>Bacillus licheniformis</i> strain NZYM-CB. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Solano MLM, Van Loveren H, Vernis L, Tokić V, Cavanna D, Liu Y.   +15 more
europepmc   +1 more source

Metabolomics of Genetically Modified Crops [PDF]

International Journal of Molecular Sciences, 2014
Metabolomic-based approaches are increasingly applied to analyse genetically modified organisms (GMOs) making it possible to obtain broader and deeper information on the composition of GMOs compared to that obtained from traditional analytical approaches.
Virginia Garcia-Cañas, Clara Ibanez, Carolina Simo   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Genetically modified allergens

Immunology and Allergy Clinics of North America, 2004
For more than 90 years, allergen-specific immunotherapy, the only causative allergy treatment, has remained basically unchanged. The development of molecular biology techniques has led to the preparation of individual recombinant allergens from the most important allergen sources.
Verena, Niederberger, Rudolf, Valenta
openaire   +2 more sources

Genetic Modifiers in Hemoglobinopathies

Current Molecular Medicine, 2008
Hereditary anemias show considerable variation in their clinical presentation. In some cases, the causes of these variations are easily apparent. In thalassemia (or in HbE/thalassemia), genetic variation is primarily caused by the severity of the thalassemia mutation.
Deborah, Rund, Suthat, Fucharoen
openaire   +2 more sources

The Ecology of Genetically Modified Mosquitoes

Science, 2002
Ecological and population biology issues constitute serious challenges to the application of genetically modified mosquitos (GMM) for disease control.
Scott, T.W., Takken, W., Knols, B.G.J., Boëte, C.   +3 more
openaire   +3 more sources

Genetically modified mice and cognition

Current Opinion in Neurobiology, 1998
Cognition in transgenic and knockout mice is preferentially assessed by spatial learning in the Morris water maze. Awareness is growing, however, that the putative cognitive deficits observed using such a paradigm may be biased by the genetic background and behavioral peculiarities of the specific animals used.
Lipp HP, Wolfer DP
openaire   +3 more sources